Navigation Links
China Cord Blood Corporation Received AABB Accreditation
Date:4/2/2013

HONG KONG, April 2, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the cord blood bank operated by its Beijing subsidiary has been granted the AABB Accreditation, as a certification of its quality excellence of providing cord blood processing and storage services.

As an indication of established quality system and proven track record, the AABB conducts an Accreditation Program which follows an intensive on-site assessment by specially trained AABB assessors and establishes that the level of technical and administrative performance within the facility meets or exceeds the standards set by AABB. 

"We are very pleased to receive the AABB Accreditation," said Ms. Ting Zheng, Chief Executive Officer of China Cord Blood Corporation.  "It demonstrates our consistent commitment of advanced learning, continuous improvement, and innovation to sustain top level of quality and safety.  Today, our effort has been recognized and validated."

AABB's Accreditation Program contributes to the quality and safety of collecting, processing, testing, distributing and administering blood and cellular therapy products, as well as assessing the quality and operational systems in place within a facility.  

Ms. Zheng concluded, "Voluntarily participating in AABB's Accreditation Program signals our commitment to achieve quality and our dedication to offer excellent quality assurance to the society that we serve."

About AABB

Established in 1947, AABB is an international, not-for-profit association dedicated the advancement of science and the practice of blood centers, transfusion medicine and related biological therapies.  The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries. For more information, please visit www.aabb.org.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.  For more information, please visit the Company's website at http://www.chinacordbloodcorp.com.    

For more information, please contact:

China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com  

ICR, Inc.
Mr. Bill Zima
Tel: (+86) 10-6583-7511 or (646) 405-5185
Email: bill.zima@icrinc.com


'/>"/>
SOURCE China Cord Blood Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Diagnostic Reagent Industry Report, 2012-2014
2. Research on China's FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017
3. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
4. China Probiotics Market 2012-2016
5. China Market Data: Acrylonitrile, Phytol and Branched Chain Amino Acids Analysis in New Research Reports at RnRMarketResearch.com
6. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
7. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
8. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
9. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
10. Lucintel’s Analysis of Growth Opportunities in China’s Composites Industry: Expect Market to Surpass $11 Billion in 2017
11. China Cord Blood Corporation to Further Consolidate its Corporate Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):